Pomalidomide, bortezomib, and dexamethasone vs bortezomib and dexamethasone in relapsed or refractory multiple myeloma (OPTIMISMM): final survival outcomes from a randomized, open-label, phase 3 trial
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023 (SCI-Expanded, Scopus)
- Publication Type: Article / Abstract
- Publication Date: 2023
- Journal Name: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
- Ankara University Affiliated: Yes